 • Breaking news and features from Europe. | | New Insights Into Open innovation
| | Open innovation is sometimes chaotic and often difficult to measure, but getting it right can give firms a real edge now and in the future. |
| | | |
| New Insights Into Open innovation
| | | Open innovation is sometimes chaotic and often difficult to measure, but getting it right can give firms a real edge now and in the future. |
| | Mentoring the Mavericks
| | | Having a 'maverick' in your company can lead to problems as well as breakthroughs and innovations. Judith Germain outlines the value of harnessing a brilliant but wayward talent. |
| | | |
 Dr Brian D. Smith
Click here to read Dr Brian D. Smith's regular column on corporate strategy. |  Gerhard Symons
Click here to read Gerhard Symon's regular column on Bio-technology. |  Jacky Law
Click here to read Jacky Law's regular column on pharma business. |  Reflector
Click here to read Reflector's regular column from the European Union. |
| 
PharmExec Blog
Follow Us
RSS
Bookstore
The New Health is the fast-morphing world of biopharma: emerging science, changing technology, rising costs, global regulations. The New Health needs an ally. More at www.quintiles.com/newhealth.
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?